Erosive Esophagitis (EE) is a condition where the esophagus, the tube connecting your mouth and stomach, gets inflamed. This study tests a new medicine, BLI5100, to see if it helps heal and maintain healing of EE compared to a standard treatment called PPI (proton pump inhibitor), which reduces stomach acid. Participants will take BLI5100 once daily for up to 8 weeks to heal the esophagus, and then continue for 24 weeks to keep it healed.
Key Points:
- Participants must be 18 or older and have had both heartburn and regurgitation recently.
- Cannot participate if you have certain stomach or esophagus conditions, or if you use specific medications.
- Study involves taking study medicine for up to 32 weeks and a few visits to see the doctor.
If you meet the study requirements, this could be a chance to try a new treatment for EE. Remember, there are rules about birth control during the study, and you should talk to your doctor to see if joining is right for you.
How understandable was the trial content above?
Hard to understand
Easy to understand